98 related articles for article (PubMed ID: 24141179)
1. Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats.
Barr AM; Wu CH; Wong C; Hercher C; Töpfer E; Boyda HN; Procyshyn RM; Honer WG; Beasley CL
Neuroscience; 2013; 255():147-57. PubMed ID: 24141179
[TBL] [Abstract][Full Text] [Related]
2. Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: Distinct roles of inhibitory and excitatory terminals.
Ramos-Miguel A; Honer WG; Boyda HN; Sawada K; Beasley CL; Procyshyn RM; Barr AM
Neuroscience; 2015 Aug; 301():298-311. PubMed ID: 26086543
[TBL] [Abstract][Full Text] [Related]
3. Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats.
Boyda HN; Ramos-Miguel A; Procyshyn RM; Töpfer E; Lant N; Choy HH; Wong R; Li L; Pang CC; Honer WG; Barr AM
Int J Neuropsychopharmacol; 2014 Jan; 17(1):77-90. PubMed ID: 23953063
[TBL] [Abstract][Full Text] [Related]
4. Decreased medial entorhinal cortical thickness in olanzapine exposed female rats is not ameliorated by exercise.
Woodward ML; Ker AH; Barr AM; Beasley CL; Hercher C; Boyda HN; Procyshyn RM; Honer WG; Lang DJ
Pharmacol Biochem Behav; 2020 Jan; 188():172834. PubMed ID: 31785244
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia.
Panenka WJ; Khorram B; Barr AM; Smith GN; Lang DJ; Kopala LC; Vandorpe RA; Honer WG
Schizophr Res; 2007 Aug; 94(1-3):288-92. PubMed ID: 17570643
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.
Vernon AC; Natesan S; Modo M; Kapur S
Biol Psychiatry; 2011 May; 69(10):936-44. PubMed ID: 21195390
[TBL] [Abstract][Full Text] [Related]
7. Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats.
Boyda HN; Procyshyn RM; Tse L; Wong D; Pang CC; Honer WG; Barr AM
Neuropharmacology; 2012 Mar; 62(3):1391-400. PubMed ID: 21376062
[TBL] [Abstract][Full Text] [Related]
8. Effects of 4-weeks of treatment with lithium and olanzapine on long-term potentiation in hippocampal area CA1.
Shim SS; Hammonds MD; Tatsuoka C; Feng IJ
Neurosci Lett; 2012 Aug; 524(1):5-9. PubMed ID: 22750162
[TBL] [Abstract][Full Text] [Related]
9. Chronic exposure to haloperidol and olanzapine leads to common and divergent shape changes in the rat hippocampus in the absence of grey-matter volume loss.
Crum WR; Danckaers F; Huysmans T; Cotel MC; Natesan S; Modo MM; Sijbers J; Williams SC; Kapur S; Vernon AC
Psychol Med; 2016 Nov; 46(15):3081-3093. PubMed ID: 27516217
[TBL] [Abstract][Full Text] [Related]
10. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine.
Wu C; Yuen J; Boyda HN; Procyshyn RM; Wang CK; Asiri YI; Pang CC; Honer WG; Barr AM
PLoS One; 2014; 9(9):e107116. PubMed ID: 25254366
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury.
Csernansky JG; Martin MV; Czeisler B; Meltzer MA; Ali Z; Dong H
Pharmacol Biochem Behav; 2006 Feb; 83(2):208-13. PubMed ID: 16524622
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-induced DNA methylation in the hippocampus and cerebellum in genes mapped to human 22q11 and implicated in schizophrenia.
Melka MG; Rajakumar N; O'Reilly R; Singh SM
Psychiatr Genet; 2015 Apr; 25(2):88-94. PubMed ID: 25415458
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus.
Pillai A; Mahadik SP
Schizophr Res; 2006 Oct; 87(1-3):48-59. PubMed ID: 16859894
[TBL] [Abstract][Full Text] [Related]
15. Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates.
Brown RW; Perna MK; Maple AM; Wilson TD; Miller BE
Brain Res; 2008 Mar; 1200():66-77. PubMed ID: 18289509
[TBL] [Abstract][Full Text] [Related]
16. Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus.
Hammonds MD; Shim SS
Basic Clin Pharmacol Toxicol; 2009 Aug; 105(2):113-9. PubMed ID: 19486334
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
Matosin N; Fernandez-Enright F; Lum JS; Andrews JL; Engel M; Huang XF; Newell KA
Schizophr Res; 2015 Aug; 166(1-3):212-8. PubMed ID: 26048293
[TBL] [Abstract][Full Text] [Related]
18. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
19. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.
Kodama M; Fujioka T; Duman RS
Biol Psychiatry; 2004 Oct; 56(8):570-80. PubMed ID: 15476686
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
